A practical approach to immunization in atopic children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 57, Issue 6, 2002, Pages 472-479

  Gruber C ^a   Niggemann, B ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; ANTIBIOTIC AGENT; GELATIN; IMMUNOLOGICAL ADJUVANT; MEASLES MUMPS RUBELLA VACCINE; NEOMYCIN; VACCINE;

ANAPHYLAXIS; ATOPY; CHILD; COMMUNICABLE DISEASE; DISEASE SEVERITY; DRUG FORMULATION; DRUG HYPERSENSITIVITY; EGG; FOOD ALLERGY; HUMAN; IMMUNIZATION; MILK ALLERGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; EUROPE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGY; RISK FACTOR; STANDARD; UNITED STATES;

CHILD; DRUG HYPERSENSITIVITY; EUROPE; HUMAN; HYPERSENSITIVITY, IMMEDIATE; IMMUNIZATION; RISK FACTORS; UNITED STATES; VACCINES; HUMANS;

EID: 0036098645     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2002.02155.x     Document Type: Review

References (65)

1. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force
2. Do early childhood immunizations influence the development of atopy and do they cause allergic reactions?
3. Vaccine safety and contraindications
4. Recommendations for using MMR vaccine in children allergic to eggs
5. Measles, mumps, and rubella - Vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
6. Vaccination strategies for children with specific medical conditions: A paediatrician's viewpoint
7. MMR vaccine and allergy
8. Allergic reactions to measles (rubella) vaccine in patients hypersensitive to egg protein
9. A prospective study of cow milk allergy in Danish infants during the first three years of life. Clinical course in relation to clinical and immunological type of hypersensitivity reaction
10. Measles vaccine in egg allergic children. Poor immunogenicity of the Edmoston-Zagreb strain
11. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella
12. Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: Cohort study
13. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles rubella and mumps
14. Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine
15. Measles immunization in children with a history of egg allergy
16. Severe hypersensitivity or intolerance reactions to measles vaccine in six children. Clinical and immunological studies
17. Early-onset reaction after measles vaccination. Further Australian reports
18. Systemic reactions to measles-mumps-rubella vaccine skin testing
19. Adverse events following immunisation associated with the 1988 Australian Measles Control Campaign
20. Verdachtsfälle unerwünschter arzneimittelwirkungen (UAW) nach anwendung von impfstoffen mit attenuierter masern-komponente. Eine übersicht der nationalen spontanerfassungsdaten 1995-1999
21. MMR-vaccination of children allergic to eggs
22. Serious adverse events after measles-mumps-rubella vaccination during a fourteen year prospective follow-up
23. Allergic reactions to measles-mumps-rubella vaccination
24. Lack of adverse reactions to measles, mumps, and rubella vaccine in egg-allergic children
25. Safe administration of the measles vaccine to children allergic to eggs
26. Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion
27. Administration of measles, mumps, and rubella virus vaccine (live) to egg-allergic children
28. Measles immunisation in children with allergy to egg
29. Measles immunization in children with clinical reactions to egg protein
30. Fatal and near fatal anaphylactic reactions to food in children and adolescents
31. Measles, mumps, rubella vaccine administration in egg-sensitive children: Systemic reactions during vaccine desensitization
32. Safe administration of influenza vaccine to patients with egg allergy
33. Dose-response in double-blind, placebo-controlled oral food challenges in children with atopic dermatitis
34. Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin
35. Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines
36. The relevance of TH1 and TH2 cells in immediate and nonimmediate reactions to gelatin-containing vaccine
37. A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin- containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids
38. Changes in gelatin content of vaccines associated with reduction in reports of allergic reactions
39. A strong association between HLA-DR9 and gelatin allergy in the Japanese population
40. Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix
41. MMR vaccine and neomycin allergy
42. Safe MMR vaccination despite neomycin allergy
43. Total and IgE antibody levels following booster immunization with aluminum absorbed and nonabsorbed tetanus toxoid in humans
44. IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (Td) toxoids
45. The influence of different adjuvants on the production of IgD and IgE antibodies
46. The common vaccine adjuvant aluminium hydroxide upregulates accessory properties of human monocytes via an IL-4-dependent mechanism
47. Vaccination granulomas and aluminium allergy, course and prognostic factors
48. Injection-site granuloma due to aluminum
49. Common allergens in avian meats
50. Exposure to formaldehyde and phenol during an anatomy dissecting course: Sensitizing potency of formaldehyde in medical students
51. Give us this day our daily germs
52. The inverse association between tuberculin responses and atopic disorder
53. Measles and atopy in Guinea-Bissau
54. Specific IgE and IgG4 immune responses to tetanus and diphtheria toxoid in atopic and nonatopic children during the first two years of life
55. Pertussis IgE and atopic disease
56. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children
57. A randomized controlled trial of the effect of pertussis vaccines on atopic disease
58. Downregulation of IgE and IgG4 antibodies to tetanus toxoid and diphtheria toxoid by covaccination with cellular Bordetella pertussis vaccine
59. Raised serum IgE associated with reduced responsiveness to DPT vaccination during infancy
60. Development of immunologic memory against tetanus toxoid and pertactin antigens from the diphtheria-tetanus-pertussis vaccine in atopic versus nonatopic children
61. Atopy in children of families with an anthroposophic lifestyle
62. Is infant immunization a risk factor for childhood asthma or allergy?
63. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States
64. Immunization and symptoms of atopic disease in children. Results from the International Study of Asthma and Allergies in Childhood